Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
The Journal of Clinical Investigation|June 1, 1996
Apolipoprotein A-I is required for cholesteryl ester accumulation in steroidogenic cells and for normal adrenal steroid productionA S Plump, S K Erickson, W Weng, et al.
Neuroscience Research|February 9, 1999
Comparison of the expression of two immediate early gene proteins, FosB and Fos in the rat preoptic area, hypothalamus and brainstem during pregnancy, parturition and lactationS H Lin, S Miyata, W Weng, et al.
Cytokine|July 20, 2002
Ccr2 regulates the level of MCP-1/CCL2 in vitro and at inflammatory sites and controls T cell activation in response to alloantigenL A Tylaska, L Boring, W Weng, et al.
Microcirculation (New York, N.Y. : 1994)|July 1, 1994
Desensitization of 5HT2 receptors by protein kinase C activation in distal pulmonary vascular smooth muscle cells in cultureW Weng, I J Reynolds, J P Jani, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 11, 1999
Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient miceR J Aiello, P A Bourassa, S Lindsey, et al.
Human Genetics|August 1, 1995
Screening for naturally occurring apolipoprotein A-I variants: apo A-I(delta K107) is associated with low HDL-cholesterol levels in men but not in womenJ R Nofer, A von Eckardstein, H Wiebusch, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 14, 1997
The murine P84 neural adhesion molecule is SHPS-1, a member of the phosphatase-binding protein familyS Comu, W Weng, S Olinsky, et al.
Journal of Lipid Research|June 5, 1999
ApoA-II maintains HDL levels in part by inhibition of hepatic lipase. Studies In apoA-II and hepatic lipase double knockout miceW Weng, N A Brandenburg, S Zhong, et al.
Clinical Pharmacology and Therapeutics|August 12, 2015
A Quantitative Framework to Evaluate Proarrhythmic Risk in a First-in-Human Study to Support Waiver of a Thorough QT StudyC H Nelson, L Wang, L Fang, et al.
The Pharmacogenomics Journal|March 16, 2016
Integrated Drug Expression Analysis for leukemia: an integrated in silico and in vivo approach to drug discoveryM H Ung, C-H Sun, C-W Weng, et al.
Pageof 7